Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies.
Pharmacology of the sphingosine-1-phosphate signalling system.
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.
Intractable Vomiting Antecedent to Optic Neuritis: An Early Clinical Clue to Neuromyelitis Optica.
Using EAE to better understand principles of immune function and autoimmune pathology.
The multiple sclerosis self-management scale: clinicometric testing.
Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
Adherence to Glatiramer Acetate 40 Mg Versus Oral Disease-Modifying Therapies for Multiple Sclerosis.
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Association of Mycobacterium avium subsp. paratuberculosis and SLC11A1 polymorphisms in Sardinian multiple sclerosis patients.
A diagnostic challenge in a young woman with intractable hiccups and vomiting: a case of neuromyelitis optica.
Calcium intervention ameliorates experimental model of multiple sclerosis.
Mood and coping in clinically isolated syndrome and multiple sclerosis.
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
B-type suppression: A role played by "regulatory B cells" or "regulatory plasma cells"?
Pathophysiology of immune-mediated demyelinating neuropathies - Part I: Neuroscience.
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Timing of cigarette smoking as a risk factor for multiple sclerosis.
The best clinical paper on multiple sclerosis in 2012.
A method for estimating intracellular sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic resonance imaging.
Pilot Trial of a Social Cognitive Theory-Based Physical Activity Intervention Delivered by Non-Supervised Technology in Persons With Multiple Sclerosis.
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?
Pages
« first
‹ previous
…
417
418
419
420
421
422
423
424
425
…
next ›
last »